These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 29073905)
1. Therapeutic application of T regulatory cells in composite tissue allotransplantation. Yang JH; Eun SC J Transl Med; 2017 Oct; 15(1):218. PubMed ID: 29073905 [TBL] [Abstract][Full Text] [Related]
2. Unraveling the Crucial Roles of FoxP3+ Regulatory T Cells in Vascularized Composite Allograft Tolerance Induction and Maintenance. Anggelia MR; Cheng HY; Chuang WY; Hsieh YH; Wang AYL; Lin CH; Wei FC; Brandacher G; Lin CH Transplantation; 2021 Jun; 105(6):1238-1249. PubMed ID: 33141809 [TBL] [Abstract][Full Text] [Related]
3. In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation. Fisher JD; Zhang W; Balmert SC; Aral AM; Acharya AP; Kulahci Y; Li J; Turnquist HR; Thomson AW; Solari MG; Gorantla VS; Little SR Sci Adv; 2020 Mar; 6(11):eaax8429. PubMed ID: 32201714 [TBL] [Abstract][Full Text] [Related]
4. Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants. Bozulic LD; Wen Y; Xu H; Ildstad ST Transplantation; 2011 Apr; 91(8):908-15. PubMed ID: 21304439 [TBL] [Abstract][Full Text] [Related]
5. The amelioration of composite tissue allograft rejection by TIM-3-modified dendritic cell: Regulation of the balance of regulatory and effector T cells. Wang Y; Zheng Z; Zhu X; Han J; Dong M; Tao K; Wang H; Wang Y; Hu D Immunol Lett; 2016 Jan; 169():15-22. PubMed ID: 26561949 [TBL] [Abstract][Full Text] [Related]
6. Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology. Leonard DA; Kurtz JM; Cetrulo CL Curr Opin Organ Transplant; 2013 Dec; 18(6):645-51. PubMed ID: 24126805 [TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells are not predictive of outcomes in a nonhuman primate model of vascularized composite allotransplantation. Brazio PS; Munivenkatappa RB; Bojovic B; Ha JS; Brown EN; Hess AS; Bartlett ST; Rodriguez ED; Barth RN Transplantation; 2013 Aug; 96(3):267-73. PubMed ID: 23839001 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation. Jindal R; Unadkat J; Zhang W; Zhang D; Ng TW; Wang Y; Jiang J; Lakkis F; Rubin P; Lee WP; Gorantla VS; Zheng XX Am J Transplant; 2015 May; 15(5):1231-40. PubMed ID: 25676865 [TBL] [Abstract][Full Text] [Related]
9. Regulatory T Cells: Liquid and Living Precision Medicine for the Future of VCA. Kauke-Navarro M; Knoedler S; Panayi AC; Knoedler L; Noel OF; Pomahac B Transplantation; 2023 Jan; 107(1):86-97. PubMed ID: 36210500 [TBL] [Abstract][Full Text] [Related]
10. The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation. Lin CH; Anggelia MR; Cheng HY; Wang AYL; Chuang WY; Lin CH; Lee WPA; Wei FC; Brandacher G Cell Mol Immunol; 2021 Feb; 18(2):363-373. PubMed ID: 31754236 [TBL] [Abstract][Full Text] [Related]
11. Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Francis RS; Feng G; Tha-In T; Lyons IS; Wood KJ; Bushell A Eur J Immunol; 2011 Mar; 41(3):726-38. PubMed ID: 21243638 [TBL] [Abstract][Full Text] [Related]
12. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg. Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939 [TBL] [Abstract][Full Text] [Related]
14. Donor bone-marrow CXCR4+ Foxp3+ T-regulatory cells are essential for costimulation blockade-induced long-term survival of murine limb transplants. Wang L; Wang Z; Han R; Samanta A; Ge G; Levin LS; Levine MH; Hancock WW Sci Rep; 2020 Jun; 10(1):9292. PubMed ID: 32518311 [TBL] [Abstract][Full Text] [Related]
15. Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation. Siemionow M; Kulahci Y; Zor F Curr Opin Organ Transplant; 2023 Dec; 28(6):431-439. PubMed ID: 37800652 [TBL] [Abstract][Full Text] [Related]
16. Limited efficacy of rapamycin monotherapy in vascularized composite allotransplantation. Xu H; Steinberger Z; Wang L; Han R; Zhang Y; Hancock WW; Levin LS Transpl Immunol; 2020 Aug; 61():101308. PubMed ID: 32535143 [TBL] [Abstract][Full Text] [Related]
17. [Study on the effect of CD4+CD25+ regulatory T cell adoptive transfusion on humoral immune function in rat composite tissue allotransplantation model]. Yang Y; Li Y; Han Y; Lu KH; Zhuang R; Xia W; Yi CG; Fan X; Guo SZ Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(1):62-5. PubMed ID: 20302759 [TBL] [Abstract][Full Text] [Related]